Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Concord
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Concord, CA

Studies commonly pay $75 to $4,500 per completed study

1,508 clinical trials are currently recruiting participants within 30 miles of Concord. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,508studies recruiting
1+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Concord right now

Top 25 of 1,508 recruiting studies, sorted by proximity — each links to its official registry page

One-Time DNA Study for Vasculitis

Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis N/A Observational 1,000 participants sought
University of California, San Francisco — San Francisco, California (26.6 mi) · Sponsor: University of Pennsylvania
See eligibility & contact on ClinicalTrials.gov (NCT01241305)

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

Graft Vs Host Disease, Graft-versus-host-disease N/A Interventional 90 participants sought
University of California, San Francisco — San Francisco, California (26.6 mi) · Sponsor: Christopher Dvorak
See eligibility & contact on ClinicalTrials.gov (NCT04337515)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
UCSF Benioff Children's Hospital Oakland — Oakland, California (18.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Bass Medical Group ( Site 0123) — Walnut Creek, California (5.7 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

Niemann-Pick Type C Disease, GM1 Gangliosidosis Phase 3 Interventional 147 participants sought
UCSF Children's Hospital and Research Center at Oakland — Oakland, California (18.7 mi) · Sponsor: Azafaros B.V.
See eligibility & contact on ClinicalTrials.gov (NCT07054515)

Intercostal Cryoanalgesia in Double Lung Transplant Recipients

Post-operative Pain Management N/A Interventional 148 participants sought
University of California San Francisco — San Francisco, California (26.6 mi) · Sponsor: University of California, Los Angeles
See eligibility & contact on ClinicalTrials.gov (NCT07281118)

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

Hypertension, Pulmonary, Lung Diseases, Interstitial Phase 2 Interventional 25 participants sought
San Francisco — San Francisco, California (26.6 mi) · Sponsor: Tectonic Operating Company, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07473700)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
Bay Area Retina Associates - Walnut Creek — Walnut Creek, California (5.7 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

NK-Cell Lymphoma, NK-Cell Leukemia EARLY/Phase 1 Interventional 40 participants sought
University of California San Francisco — San Francisco, California (26.6 mi) · Sponsor: New York Medical College
See eligibility & contact on ClinicalTrials.gov (NCT03719105)

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Melanoma Stage III, Melanoma Stage IV Phase 2 Interventional 25 participants sought
University of California, San Francisco — San Francisco, California (26.6 mi) · Sponsor: University of California, San Francisco
See eligibility & contact on ClinicalTrials.gov (NCT04598009)

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Papillary Thyroid Cancer, Pediatric Cancer N/A Observational 32 participants sought
University of California San Francisco — San Francisco, California (26.6 mi) · Sponsor: Children's Hospital of Philadelphia
See eligibility & contact on ClinicalTrials.gov (NCT05024929)

Contingency Management for Veteran Smokers Undergoing Major Elective Surgery

Tobacco Use Disorder, Substance Use Disorder (SUD) N/A Interventional 36 participants sought
San Francisco VA Health Care System — San Francisco, California (26.6 mi) · Sponsor: University of California, San Francisco
See eligibility & contact on ClinicalTrials.gov (NCT06678672)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — San Francisco, California (26.6 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

Osteoporotic Fractures, Osteoporosis N/A Observational 648 participants sought
University of California San Francisco (USCF) Department of Orthopaedic Surgery — San Francisco, California (26.6 mi) · Sponsor: AO Foundation, AO Spine
See eligibility & contact on ClinicalTrials.gov (NCT07027306)

A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma

Neuroblastoma Recurrent Phase 2 Interventional 54 participants sought
University of California San Francisco — San Francisco, California (26.6 mi) · Sponsor: St. Jude Children's Research Hospital
See eligibility & contact on ClinicalTrials.gov (NCT07085338)

Gauging Outcomes of Total Milk Ingestion on Lipid and gControl

Heart Diseases, Cardiovascular Disease N/A Interventional 110 participants sought
UCSF Medical Center at Parnassus — San Francisco, California (26.6 mi) · Sponsor: University of California, San Francisco
See eligibility & contact on ClinicalTrials.gov (NCT07087184)

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative Phase 3 Interventional 882 participants sought
University of California San Francisco — San Francisco, California (26.6 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07196748)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
University of California San Francisco UCSF The Madison Clinic for Pediatric Diabetes — San Francisco, California (26.6 mi) · Sponsor: Medtronic MiniMed, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07228117)

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Parkinson Disease N/A Observational 4,500 participants sought
University of California, San Francisco — San Francisco, California (26.6 mi) · Sponsor: Michael J. Fox Foundation for Parkinson's Research
See eligibility & contact on ClinicalTrials.gov (NCT04477785)

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

Meningioma Phase 1 Interventional 50 participants sought
University of California, San Francisco — San Francisco, California (26.6 mi) · Sponsor: Javier Villaneuva-Meyer, MD
See eligibility & contact on ClinicalTrials.gov (NCT06014905)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — San Francisco, California (26.6 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)
Actively enrolling

Studies you may be able to join near Concord

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Concord

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

John Muir Health Clinical Research Center

2700 Grant St #102, Concord, CA 94520
(925) 674-2580

Clinical trials in Concord: what's recruiting

The Concord area currently has 1,508 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Concord, the most active research areas are:

  • Cancer & Oncology11 studies
  • Diabetes & Metabolism3 studies
  • Heart & Vascular2 studies
  • Lungs & Breathing1 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Concord, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Concord

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Concord participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Concord pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Concord?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Concord safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How often do new paid studies open in Concord?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Concord.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Concord typically complete one or two studies per year.

Paid clinical trials near Concord

Other metros within reach

Antioch, CA456 Vallejo, CA1,496 Oakland, CA2,247 Fairfield, CA346 Hayward, CA2,256 Fremont, CA2,246 San Francisco, CA2,229 Sunnyvale, CA1,156

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Concord Chronic Kidney Disease (HealthMatch) in Concord Bladder Issues Due To Spinal Cord Injury in Concord All conditions

More of CA

Long Beach3,373 Torrance3,260 Fullerton3,257 Anaheim3,199 Garden Grove3,191 Pomona3,156 Glendale2,966 Los Angeles2,950 Huntington Beach2,870 Santa Clarita2,384 Hayward2,256 Oakland2,247

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts